Skip to main content
GENESIS IBRC INDIA LIMITED logo

GENESIS IBRC INDIA LIMITED — Investor Relations & Filings

Ticker · 514336 ISIN · INE194N01016 BSE.NS Manufacturing
Filings indexed 311 across all filing types
Latest filing 2026-01-06 Regulatory Filings
Country IN India
Listing BSE.NS 514336

About GENESIS IBRC INDIA LIMITED

https://genesisiil.com/

Genesis IBRC India Limited is a biotechnology-driven enterprise focused on the research, development, and commercialization of advanced biological solutions. The company specializes in the production of high-quality probiotics and industrial enzymes tailored for diverse applications. Its product portfolio serves critical sectors including aquaculture, poultry, animal husbandry, and human nutrition, providing microbial formulations designed to enhance growth, immunity, and overall health. In the industrial segment, the company develops enzymatic solutions for the textile, leather, and paper processing sectors to improve efficiency and environmental sustainability. Genesis IBRC emphasizes innovation through its dedicated research facilities, focusing on strain selection and fermentation technology to deliver standardized and effective biochemical products. The company aims to provide science-based alternatives to traditional chemical processes across global markets.

Recent filings

Filing Released Lang Actions
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for V Varalakshmi & Padmanaban Krishnamorrthy
Regulatory Filings
2026-01-06 English
Resignation of Company Secretary of the Company
Regulatory Filings
2025-12-31 English
Closure of trading window for the quarter ended on 31.12.2025
Regulatory Filings Classification · 95% confidence The document is a formal notice from Genesis IBRC India Limited addressed to the BSE Limited regarding the closure of the trading window for insiders. It references compliance with SEBI regulations on insider trading and specifies the closure period around the announcement of unaudited financial results for the third quarter ending December 31, 2025. The document does not contain any financial data, results, or detailed report content but is an announcement related to trading restrictions ahead of financial results disclosure. The document length is short (1451 characters), and it serves as an informational notice rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-12-26 English
Swaraj Shares and Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer Public Announcement to the public shareholders of Genesis Ibrc India Ltd ("Target Company").
Regulatory Filings
2025-12-23 English
Swaraj Shares and Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-offer Advertisement and Corrigendum to the Detailed Public Statement under Regulation 18(7) ....
Regulatory Filings
2025-11-25 English
Swaraj Shares and Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors ('IDC') of Genesis Ibrc India Ltd ....
Regulatory Filings
2025-11-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.